Random-Forest-Algorithm-Based Applications of the Basic Characteristics and Serum and Imaging Biomarkers to Diagnose Mild Cognitive Impairment
Mild cognitive impairment (MCI) is considered the early stage of Alzheimer's Disease (AD). The purpose of our study was to analyze the basic characteristics and serum and imaging biomarkers for the diagnosis of MCI patients as a more objective and accurate approach. The Montreal Cognitive Test...
Uložené v:
| Vydané v: | Current Alzheimer research Ročník 19; číslo 1; s. 76 |
|---|---|
| Hlavní autori: | , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United Arab Emirates
01.01.2022
|
| Predmet: | |
| ISSN: | 1875-5828, 1875-5828 |
| On-line prístup: | Zistit podrobnosti o prístupe |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Mild cognitive impairment (MCI) is considered the early stage of Alzheimer's Disease (AD). The purpose of our study was to analyze the basic characteristics and serum and imaging biomarkers for the diagnosis of MCI patients as a more objective and accurate approach.
The Montreal Cognitive Test was used to test 119 patients aged ≥65. Such serum biomarkers were detected as preprandial blood glucose, triglyceride, total cholesterol, Aβ1-40, Aβ1-42, and P-tau. All the subjects were scanned with 1.5T MRI (GE Healthcare, WI, USA) to obtain DWI, DTI, and ASL images. DTI was used to calculate the anisotropy fraction (FA), DWI was used to calculate the apparent diffusion coefficient (ADC), and ASL was used to calculate the cerebral blood flow (CBF). All the images were then registered to the SPACE of the Montreal Neurological Institute (MNI). In 116 brain regions, the medians of FA, ADC, and CBF were extracted by automatic anatomical labeling. The basic characteristics included gender, education level, and previous disease history of hypertension, diabetes, and coronary heart disease. The data were randomly divided into training sets and test ones. The recursive random forest algorithm was applied to the diagnosis of MCI patients, and the recursive feature elimination (RFE) method was used to screen the significant basic features and serum and imaging biomarkers. The overall accuracy, sensitivity, and specificity were calculated, respectively, and so were the ROC curve and the area under the curve (AUC) of the test set.
When the variable of the MCI diagnostic model was an imaging biomarker, the training accuracy of the random forest was 100%, the correct rate of the test was 86.23%, the sensitivity was 78.26%, and the specificity was 100%. When combining the basic characteristics, the serum and imaging biomarkers as variables of the MCI diagnostic model, the training accuracy of the random forest was found to be 100%; the test accuracy was 97.23%, the sensitivity was 94.44%, and the specificity was 100%. RFE analysis showed that age, Aβ1-40, and cerebellum_4_6 were the most important basic feature, serum biomarker, imaging biomarker, respectively.
Imaging biomarkers can effectively diagnose MCI. The diagnostic capacity of the basic trait biomarkers or serum biomarkers for MCI is limited, but their combination with imaging biomarkers can improve the diagnostic capacity, as indicated by the sensitivity of 94.44% and the specificity of 100% in our model. As a machine learning method, a random forest can help diagnose MCI effectively while screening important influencing factors. |
|---|---|
| AbstractList | Mild cognitive impairment (MCI) is considered the early stage of Alzheimer's Disease (AD). The purpose of our study was to analyze the basic characteristics and serum and imaging biomarkers for the diagnosis of MCI patients as a more objective and accurate approach.BACKGROUNDMild cognitive impairment (MCI) is considered the early stage of Alzheimer's Disease (AD). The purpose of our study was to analyze the basic characteristics and serum and imaging biomarkers for the diagnosis of MCI patients as a more objective and accurate approach.The Montreal Cognitive Test was used to test 119 patients aged ≥65. Such serum biomarkers were detected as preprandial blood glucose, triglyceride, total cholesterol, Aβ1-40, Aβ1-42, and P-tau. All the subjects were scanned with 1.5T MRI (GE Healthcare, WI, USA) to obtain DWI, DTI, and ASL images. DTI was used to calculate the anisotropy fraction (FA), DWI was used to calculate the apparent diffusion coefficient (ADC), and ASL was used to calculate the cerebral blood flow (CBF). All the images were then registered to the SPACE of the Montreal Neurological Institute (MNI). In 116 brain regions, the medians of FA, ADC, and CBF were extracted by automatic anatomical labeling. The basic characteristics included gender, education level, and previous disease history of hypertension, diabetes, and coronary heart disease. The data were randomly divided into training sets and test ones. The recursive random forest algorithm was applied to the diagnosis of MCI patients, and the recursive feature elimination (RFE) method was used to screen the significant basic features and serum and imaging biomarkers. The overall accuracy, sensitivity, and specificity were calculated, respectively, and so were the ROC curve and the area under the curve (AUC) of the test set.METHODSThe Montreal Cognitive Test was used to test 119 patients aged ≥65. Such serum biomarkers were detected as preprandial blood glucose, triglyceride, total cholesterol, Aβ1-40, Aβ1-42, and P-tau. All the subjects were scanned with 1.5T MRI (GE Healthcare, WI, USA) to obtain DWI, DTI, and ASL images. DTI was used to calculate the anisotropy fraction (FA), DWI was used to calculate the apparent diffusion coefficient (ADC), and ASL was used to calculate the cerebral blood flow (CBF). All the images were then registered to the SPACE of the Montreal Neurological Institute (MNI). In 116 brain regions, the medians of FA, ADC, and CBF were extracted by automatic anatomical labeling. The basic characteristics included gender, education level, and previous disease history of hypertension, diabetes, and coronary heart disease. The data were randomly divided into training sets and test ones. The recursive random forest algorithm was applied to the diagnosis of MCI patients, and the recursive feature elimination (RFE) method was used to screen the significant basic features and serum and imaging biomarkers. The overall accuracy, sensitivity, and specificity were calculated, respectively, and so were the ROC curve and the area under the curve (AUC) of the test set.When the variable of the MCI diagnostic model was an imaging biomarker, the training accuracy of the random forest was 100%, the correct rate of the test was 86.23%, the sensitivity was 78.26%, and the specificity was 100%. When combining the basic characteristics, the serum and imaging biomarkers as variables of the MCI diagnostic model, the training accuracy of the random forest was found to be 100%; the test accuracy was 97.23%, the sensitivity was 94.44%, and the specificity was 100%. RFE analysis showed that age, Aβ1-40, and cerebellum_4_6 were the most important basic feature, serum biomarker, imaging biomarker, respectively.RESULTSWhen the variable of the MCI diagnostic model was an imaging biomarker, the training accuracy of the random forest was 100%, the correct rate of the test was 86.23%, the sensitivity was 78.26%, and the specificity was 100%. When combining the basic characteristics, the serum and imaging biomarkers as variables of the MCI diagnostic model, the training accuracy of the random forest was found to be 100%; the test accuracy was 97.23%, the sensitivity was 94.44%, and the specificity was 100%. RFE analysis showed that age, Aβ1-40, and cerebellum_4_6 were the most important basic feature, serum biomarker, imaging biomarker, respectively.Imaging biomarkers can effectively diagnose MCI. The diagnostic capacity of the basic trait biomarkers or serum biomarkers for MCI is limited, but their combination with imaging biomarkers can improve the diagnostic capacity, as indicated by the sensitivity of 94.44% and the specificity of 100% in our model. As a machine learning method, a random forest can help diagnose MCI effectively while screening important influencing factors.CONCLUSIONImaging biomarkers can effectively diagnose MCI. The diagnostic capacity of the basic trait biomarkers or serum biomarkers for MCI is limited, but their combination with imaging biomarkers can improve the diagnostic capacity, as indicated by the sensitivity of 94.44% and the specificity of 100% in our model. As a machine learning method, a random forest can help diagnose MCI effectively while screening important influencing factors. Mild cognitive impairment (MCI) is considered the early stage of Alzheimer's Disease (AD). The purpose of our study was to analyze the basic characteristics and serum and imaging biomarkers for the diagnosis of MCI patients as a more objective and accurate approach. The Montreal Cognitive Test was used to test 119 patients aged ≥65. Such serum biomarkers were detected as preprandial blood glucose, triglyceride, total cholesterol, Aβ1-40, Aβ1-42, and P-tau. All the subjects were scanned with 1.5T MRI (GE Healthcare, WI, USA) to obtain DWI, DTI, and ASL images. DTI was used to calculate the anisotropy fraction (FA), DWI was used to calculate the apparent diffusion coefficient (ADC), and ASL was used to calculate the cerebral blood flow (CBF). All the images were then registered to the SPACE of the Montreal Neurological Institute (MNI). In 116 brain regions, the medians of FA, ADC, and CBF were extracted by automatic anatomical labeling. The basic characteristics included gender, education level, and previous disease history of hypertension, diabetes, and coronary heart disease. The data were randomly divided into training sets and test ones. The recursive random forest algorithm was applied to the diagnosis of MCI patients, and the recursive feature elimination (RFE) method was used to screen the significant basic features and serum and imaging biomarkers. The overall accuracy, sensitivity, and specificity were calculated, respectively, and so were the ROC curve and the area under the curve (AUC) of the test set. When the variable of the MCI diagnostic model was an imaging biomarker, the training accuracy of the random forest was 100%, the correct rate of the test was 86.23%, the sensitivity was 78.26%, and the specificity was 100%. When combining the basic characteristics, the serum and imaging biomarkers as variables of the MCI diagnostic model, the training accuracy of the random forest was found to be 100%; the test accuracy was 97.23%, the sensitivity was 94.44%, and the specificity was 100%. RFE analysis showed that age, Aβ1-40, and cerebellum_4_6 were the most important basic feature, serum biomarker, imaging biomarker, respectively. Imaging biomarkers can effectively diagnose MCI. The diagnostic capacity of the basic trait biomarkers or serum biomarkers for MCI is limited, but their combination with imaging biomarkers can improve the diagnostic capacity, as indicated by the sensitivity of 94.44% and the specificity of 100% in our model. As a machine learning method, a random forest can help diagnose MCI effectively while screening important influencing factors. |
| Author | Jiao, Ronghong Liu, Xueyuan Wang, Lingling Yang, Juan Sui, Haijing Deng, Wenping Zhao, Xiaohui Zhang, Min |
| Author_xml | – sequence: 1 givenname: Juan surname: Yang fullname: Yang, Juan organization: Department of Neurology, Shanghai Pudong New Area People's Hospital,Shanghai, 201299, China – sequence: 2 givenname: Haijing surname: Sui fullname: Sui, Haijing organization: Department of Radiology, Shanghai Pudong New Area People's Hospital, Shanghai, People's Republic of China – sequence: 3 givenname: Ronghong surname: Jiao fullname: Jiao, Ronghong organization: Department of Clinical Laboratory, Shanghai Pudong New Area People's Hospital, Shanghai, People's Republic of China – sequence: 4 givenname: Min surname: Zhang fullname: Zhang, Min organization: hcit.ai Co., Shanghai, People's Republic of China – sequence: 5 givenname: Xiaohui surname: Zhao fullname: Zhao, Xiaohui organization: hcit.ai Co., Shanghai, People's Republic of China – sequence: 6 givenname: Lingling surname: Wang fullname: Wang, Lingling organization: Department of Neurology, Shanghai Pudong New Area People's Hospital, Shanghai, People's Republic of China – sequence: 7 givenname: Wenping surname: Deng fullname: Deng, Wenping organization: Huawei Technology Co., Ltd Co, Shanghai, People's Republic of China – sequence: 8 givenname: Xueyuan surname: Liu fullname: Liu, Xueyuan organization: Department of Neurology, Shanghai Pudong New Area People's Hospital,Shanghai, 201299, China |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35088670$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkN1KAzEQhYNUtFZfQeKdN6tJ9i-5bKvVQkXw53pJk9ltcDdZk6zgS_jMLlrBm5kD5-MMZ07QxDoLCF1QcsVomV3TvCgZyQkVRVEwRijjlBHBygM0pbzMk5wzPvmnj9BxmhPOi5JM0deTtNp1ycp5CDGZt43zJu66ZCEDaDzv-9YoGY2zAbsaxx3g0TEKL3fSSxXBmxCNCniMwc_gh-5HrTvZGNvghXGd9G_gA44O3xjZWBcAP5hW46VrrInmA0a6l8Z3YOMpOqxlG-Bsv2fodXX7srxPNo936-V8k6gspzGRElIuVFYywTOdqnEITSkQ4CLVwIusThnVBIiQQBQTtdacp1zmXJSgtmyGLn9ze-_eh7F51ZmgoG2lBTeEihVsPMDSNBvR8z06bDvQVe_NWOmz-vsh-waK83Zj |
| CitedBy_id | crossref_primary_10_1097_MD_0000000000034979 crossref_primary_10_3389_fnhum_2024_1378896 crossref_primary_10_3390_jdad2030028 crossref_primary_10_1136_bmjopen_2023_075466 crossref_primary_10_3389_fpsyt_2023_1266548 crossref_primary_10_1016_j_gerinurse_2025_103530 crossref_primary_10_1186_s12880_025_01645_w crossref_primary_10_4103_NI_Neurol_India_D_23_00014 crossref_primary_10_1186_s12920_024_01995_4 crossref_primary_10_2196_59370 |
| ContentType | Journal Article |
| Copyright | Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net. |
| Copyright_xml | – notice: Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.2174/1567205019666220128120927 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| EISSN | 1875-5828 |
| ExternalDocumentID | 35088670 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: Fund of Shanghai Municipal Health Commission grantid: 202140101 – fundername: Training Program for Academic Pioneers in Pudong New Area grantid: PWRD2020-02 – fundername: Multi-center clinical study of graded diagnosis and treatment of early cognitive dysfunction grantid: 17411950100 |
| GroupedDBID | CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c451t-aae389c472984d3c84d9d11e0e893de864f321d0e09ae0c29fdd8838a5897ecb2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 9 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000826095800007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1875-5828 |
| IngestDate | Fri Jul 11 05:59:44 EDT 2025 Thu Jan 02 22:55:13 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | algorithms screening mild cognitive impairment cognitive dysfunction Machine learning diagnostic tool |
| Language | English |
| License | Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c451t-aae389c472984d3c84d9d11e0e893de864f321d0e09ae0c29fdd8838a5897ecb2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://doi.org/10.2174/1567205019666220128120927 |
| PMID | 35088670 |
| PQID | 2623892334 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2623892334 pubmed_primary_35088670 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-01-01 |
| PublicationDateYYYYMMDD | 2022-01-01 |
| PublicationDate_xml | – month: 01 year: 2022 text: 2022-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | United Arab Emirates |
| PublicationPlace_xml | – name: United Arab Emirates |
| PublicationTitle | Current Alzheimer research |
| PublicationTitleAlternate | Curr Alzheimer Res |
| PublicationYear | 2022 |
| Score | 2.3948119 |
| Snippet | Mild cognitive impairment (MCI) is considered the early stage of Alzheimer's Disease (AD). The purpose of our study was to analyze the basic characteristics... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 76 |
| SubjectTerms | Aged Algorithms Alzheimer Disease - diagnostic imaging Biomarkers Cognitive Dysfunction - diagnostic imaging Humans Magnetic Resonance Imaging - methods |
| Title | Random-Forest-Algorithm-Based Applications of the Basic Characteristics and Serum and Imaging Biomarkers to Diagnose Mild Cognitive Impairment |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/35088670 https://www.proquest.com/docview/2623892334 |
| Volume | 19 |
| WOSCitedRecordID | wos000826095800007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEA6-EC8-8P0igtdg82ibnGRdFQVdRFT2tqRJVgu77bqt_gx_s5NsF_UgCF5CoU1p0-nky3xfZhA6Fp4M0paSJDaGCLAKklGdEZrFXFMupQp5up9u0k5Hdrvqrgm4VY2scuoTg6O2pfEx8hMG87QENMLF6eiV-KpRnl1tSmjMonkOUMZLutJu2P0GMJx4RmgRHXm1M-DuE1ippCyKfUKYJGEscEgsUiz9HVyGSeZy5b-Pt4qWG3iJWxN7WEMzrlhHH_e6sOALfRnOqiatwTP0rF-G5AymMItb3zhsXPYxQEIMZ3KD2z-zOWO4DQbn8jYMR9fDUOEIn-Xl0It8xhWuS3w-0e45fJsPLG5P1Ulw9UjnYx-L3ECPlxcP7SvS1GEgRsS0Jlo7eDcjAIdLYbmBRllKXeQA7FgnE9HnjNrIRUq7yDDVt1ZKLnUsVepMxjbRXFEWbhvhyPAs9RlvYp8iQqiM2sTaRBmTGJ1psYOOpsPbAzv35IUuXPlW9b4GeAdtTb5RbzRJyNHjHmUmabT7h957aIn5HQwhirKP5vvwl7sDtGDe67waHwYDgrZzd_sJ8F3Rkg |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Random-Forest-Algorithm-Based+Applications+of+the+Basic+Characteristics+and+Serum+and+Imaging+Biomarkers+to+Diagnose+Mild+Cognitive+Impairment&rft.jtitle=Current+Alzheimer+research&rft.au=Yang%2C+Juan&rft.au=Sui%2C+Haijing&rft.au=Jiao%2C+Ronghong&rft.au=Zhang%2C+Min&rft.date=2022-01-01&rft.issn=1875-5828&rft.eissn=1875-5828&rft.volume=19&rft.issue=1&rft.spage=76&rft_id=info:doi/10.2174%2F1567205019666220128120927&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1875-5828&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1875-5828&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1875-5828&client=summon |